Advance your academic career, collaborate globally, and expand your network— join now !

Prof. Maria Santos-Martinez

School of Pharmacy & Pharmaceutical Sciences, School of Medicine, Trinity Colleg...

Share Link

Share

Information

Dr. Maria Jose Santos-Martinez is a medical doctor, specialist in respiratory medicine, from the Universidad Autónoma de Barcelona (Spain). She started her training as a basic researcher at The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases at UTHealth (University of Texas Health Science-Houston-USA) in 2004. In 2006, she moved to Ireland and defended her PhD in 2009 (Trinity College, Dublin). She was appointed as Assistant Professor (Ussher) in Nanopharmaceutical Drug Discovery in 2010 and is currently an Associate Professor at the School of Pharmacy and Pharmaceutical Sciences & School of Medicine. Her research is mainly focused on the contribution of platelets to cancer progression (tumor invasion, angiogenesis, and blood metastasis) and blood compatibility of nanomaterials.

Research Keywords & Expertise

Cancer
Nanomedicine
Nanotoxicology
Pharmacology
Blood Platelets

Fingerprints

28%
Pharmacology
14%
Cancer
14%
Blood Platelets
5%
Nanomedicine
5%
Nanotoxicology
5%
Nanoparticle-cell

Short Biography

Dr. Maria Jose Santos-Martinez is a medical doctor, specialist in respiratory medicine, from the Universidad Autónoma de Barcelona (Spain). She started her training as a basic researcher at The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases at UTHealth (University of Texas Health Science-Houston-USA) in 2004. In 2006, she moved to Ireland and defended her PhD in 2009 (Trinity College, Dublin). She was appointed as Assistant Professor (Ussher) in Nanopharmaceutical Drug Discovery in 2010 and is currently an Associate Professor at the School of Pharmacy and Pharmaceutical Sciences & School of Medicine. Her research is mainly focused on the contribution of platelets to cancer progression (tumor invasion, angiogenesis, and blood metastasis) and blood compatibility of nanomaterials.